Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Cambridge Nutritional Sciences plc (RVKA.F)

Compare
0.0230
-0.0020
(-8.00%)
At close: April 4 at 3:29:02 PM GMT+2
Loading Chart for RVKA.F
  • Previous Close 0.0250
  • Open 0.0260
  • Bid 0.0245 x --
  • Ask 0.0635 x --
  • Day's Range 0.0230 - 0.0260
  • 52 Week Range 0.0230 - 0.0500
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 7.856M
  • Beta (5Y Monthly) 4.14
  • PE Ratio (TTM)
  • EPS (TTM) 0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cambridge Nutritional Sciences plc, together with its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, North America, South/Central America, India, rest of Asia and the Far East, Africa, and the Middle East. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the FoodPrint brand. It also provides clinical analysis to the general public, clinics, and health professionals; and supplies Food Detective, a food sensitivity test. In addition, the company offers My Health Tracker, a health app for tracking symptoms, accessing FoodPrint results, and managing gut health; and CNS Lab, which provides laboratory services for food sensitivity. It serves the government, private hospitals and clinics, reference laboratories, nutritionists, naturopaths, and functional medicine healthcare professionals. The company was formerly known as Omega Diagnostics Group PLC and changed its name to Cambridge Nutritional Sciences plc in September 2023. Cambridge Nutritional Sciences plc is based in London, the United Kingdom.

www.cnsplc.com

94

Full Time Employees

March 31

Fiscal Year Ends

Recent News: RVKA.F

View More

Performance Overview: RVKA.F

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

RVKA.F
6.12%
FTSE 100 (^FTSE)
1.44%

1-Year Return

RVKA.F
39.47%
FTSE 100 (^FTSE)
0.99%

3-Year Return

RVKA.F
59.65%
FTSE 100 (^FTSE)
6.56%

5-Year Return

RVKA.F
96.70%
FTSE 100 (^FTSE)
48.74%

Compare To: RVKA.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RVKA.F

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    8.54M

  • Enterprise Value

    3.23M

  • Trailing P/E

    20.90

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.55

  • Price/Book (mrq)

    0.52

  • Enterprise Value/Revenue

    0.30

  • Enterprise Value/EBITDA

    6.63

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.94%

  • Return on Assets (ttm)

    -1.35%

  • Return on Equity (ttm)

    1.85%

  • Revenue (ttm)

    8.97M

  • Net Income Avi to Common (ttm)

    174k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.52M

  • Total Debt/Equity (mrq)

    0.83%

  • Levered Free Cash Flow (ttm)

    212.75k

Research Analysis: RVKA.F

View More

Company Insights: RVKA.F

Research Reports: RVKA.F

View More